Sign In
Buy EW
$86.00
-1.66 (-1.89%)
At Close: Jun 03, 2026
Edwards Lifesciences CEO on the state of elective surgeries amid pandemic
09:23pm, Thursday, 10'th Dec 2020
Edward Lifesciences CEO Mike Mussallem explained why he is concerned about how patients with structural heart disease are being treated for health issues as hospitals are overwhelmed by Covid-19 patie
Edwards Lifesciences Outlines Growth Strategy At Annual Investor Conference
09:05am, Thursday, 10'th Dec 2020
IRVINE, Calif., Dec. 10, 2020 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW) will discuss the company's strategy for longer-term growth, provide an update on its technology pipeline and s
7 ESG Investing Ideas That Could Add to Your Wallet and to Your Soul
05:46am, Monday, 30'th Nov 2020
ESG investing can help create value both for society and shareholders. These seven ESG stocks are a good place to start.
Edwards Lifesciences Research Update: Dislocation In Valuation Remains
08:17pm, Tuesday, 27'th Oct 2020
Strong Q3 exit with +6.4% growth in TAVR therapy sales, in spite of pressures from COVID-19. Shareholders have enjoyed +70% gains since March, however, with high volatility to the downside, which need
Were Hedge Funds Wrong About Edwards Lifesciences Corporation (EW)?
10:04pm, Monday, 26'th Oct 2020
In this article we will take a look at whether hedge funds think Edwards Lifesciences Corporation (NYSE:EW) is a good investment right now. We check hedge fund and billionaire investor sentiment befor
Vestmark Advisory Solutions Inc. Decreases Stock Position in Edwards Lifesciences Co. (NYSE:EW)
10:01am, Thursday, 22'nd Oct 2020
Vestmark Advisory Solutions Inc. lessened its stake in Edwards Lifesciences Co. (NYSE:EW) by 6.7% in the third quarter, according to the company in its most recent 13F filing with the Securities and E
The Daily Biotech Pulse: FDA Vaccine Committee Meeting, Roche In $350M Deal for COVID-19 Treatment, Edwards Lifesciences Reports Q3 Beat
12:00am, Thursday, 22'nd Oct 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Oct. 21)
Amicus Therapeutics, Inc. (...
Lisa Edwards wird Chief Operating Officer bei Diligent Corporation
12:00am, Friday, 16'th Oct 2020
Diligent Corporation, ein weltweit führendes zukunftsorientiertes Governance-Unternehmen, auf das fast 700.000 Vorstandsmitglieder und Führungskräfte
Edwards Lifesciences Co. (NYSE:EW) Stake Lessened by Tributary Capital Management LLC
07:17am, Thursday, 15'th Oct 2020
Tributary Capital Management LLC cut its stake in Edwards Lifesciences Co. (NYSE:EW) by 2.5% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commissio
Edwards Lifesciences Co. (NYSE:EW) Position Raised by Flagship Harbor Advisors LLC
06:26am, Thursday, 15'th Oct 2020
Flagship Harbor Advisors LLC increased its position in shares of Edwards Lifesciences Co. (NYSE:EW) by 12.6% during the 3rd quarter, according to the company in its most recent Form 13F filing with th
Edwards Lifesciences Co. (NYSE:EW) CFO Scott B. Ullem Sells 33,150 Shares
04:40am, Wednesday, 14'th Oct 2020
Edwards Lifesciences Co. (NYSE:EW) CFO Scott B. Ullem sold 33,150 shares of Edwards Lifesciences stock in a transaction on Monday, October 12th. The stock was sold at an average price of $83.81, for a
Hunt Valve Company Announces Senior Leadership Change
12:00am, Tuesday, 13'th Oct 2020
Hunt Valve Company announces that Charles Ferrer has been promoted to President & Chief Executive Officer. He joins and will report to the Board o
Cypress Capital Group Trims Stock Position in Edwards Lifesciences Corp (NYSE:EW)
08:44am, Saturday, 10'th Oct 2020
Cypress Capital Group lessened its holdings in shares of Edwards Lifesciences Corp (NYSE:EW) by 9.7% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities
Exane Derivatives Trims Position in Edwards Lifesciences Corp (NYSE:EW)
08:00am, Saturday, 10'th Oct 2020
Exane Derivatives decreased its position in shares of Edwards Lifesciences Corp (NYSE:EW) by 3.9% during the 3rd quarter, according to its most recent disclosure with the SEC. The firm owned 5,178 sha
First Hawaiian Bank Has $1.16 Million Holdings in Edwards Lifesciences Corp (NYSE:EW)
07:57am, Thursday, 08'th Oct 2020
First Hawaiian Bank lowered its stake in Edwards Lifesciences Corp (NYSE:EW) by 22.1% in the third quarter, Holdings Channel.com reports. The institutional investor owned 14,559 shares of the medical
